+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Study on the muellerian duct inhibiting capability of the young rooster testis after administration of the anti androgenic drug cyproterone acetate



Study on the muellerian duct inhibiting capability of the young rooster testis after administration of the anti androgenic drug cyproterone acetate



Acta Morphologica Neerlando-Scandinavica 14(3): 242




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 027499023

Download citation: RISBibTeXText


Related references

Muellerian duct inhibiting capability of young rooster testis after administration of cyproterone acetate. Anatomical Record 184(3): 585-586, 1976

The muellerian duct inhibiting capability of young chicken testes after administration of the anti androgen cyproterone acetate. General & Comparative Endocrinology 29(2): 276-277, 1976

Is the anti-Müllerian hormone, produced by young rooster testes, an androgenic steroid? An electron microscopic study after administration of cyproterone-acetate. Journal of Anatomy 129(Pt 1): 194-196, 1979

Muellerian duct inhibiting capability of young rooster testes of various breeds after post hatching administration of a single dose of estradiol benzoate. Anatomical Record 196(3): 233A, 1980

Muellerian duct inhibiting capability of young rooster testes under several experimental conditions. Acta Morphologica Neerlando Scandinavica: 242-243, 1979

Differences in muellerian duct inhibiting capability of young rooster testes at various ages. Verhandlungen der Anatomischen Gesellschaft 75: 471-474, 1981

Nature of the anti muellerian hormone as tested by electron microscope study of young rooster testes after cyproterone acetate treatment. Anatomical Record 190(2): 407-408, 1978

Prolonged treatment of young roosters with estradiol benzoate or testosterone propionate and the effect on the muellerian duct inhibiting capability. Anatomical Record 199(3): 101A, 1981

Muellerian duct regressing capability of the embryonic chicken testis. Anatomical Record 178(2): 512-513, 1974

Bio availability and pharmaco kinetics of cyproterone acetate after oral administration of 2.0 milligrams cyproterone acetate in combination with 50 micrograms ethynyl estradiol to 6 young women. Contraception 15(5): 579-588, 1977

Corticotropin releasing hormone acth suppression by an anti androgenic drug cyproterone acetate a therapeutic possibility for congenital adrenal hyperplasia. Lee, Peter A Et Al (Ed ) Congenital Adrenal Hyperplasia Symposium Baltimore, Md , Usa, Oct 20-24, 1975 Xxii+532p Illus University Park Press: Baltimore, Md , Usa; London, England ISBN 0-8391-0974-1: 217-230, 1977

Investigations on the mechanism of action of anti androgenic cyproterone and cyproterone acetate in humans gonadotropin plasma testosterone and morphological generative gland investigations. Medizinische Welt 29: 1336, 1970

Cyproterone acetate an anti androgenic progestogen. Journal de Gynecologie Obstetrique et biologie de la Reproduction 11(1): 178, 1982

Hepatic metabolism and the anti-androgenic activity of cyproterone acetate. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 122(4): 1116-1118, 1966

Study of testicular anti muellerian hormone in persistent muellerian duct syndrome. Pediatric Research 24(4): 540, 1988